Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caterpillar
CAT
|
+$2.18B |
| 2 |
UBS Group
UBS
|
+$1.78B |
| 3 |
AbbVie
ABBV
|
+$1.76B |
| 4 |
Apple
AAPL
|
+$1.65B |
| 5 |
Home Depot
HD
|
+$1.51B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.35B |
| 2 |
UnitedHealth
UNH
|
+$2.33B |
| 3 |
JPMorgan Chase
JPM
|
+$1.99B |
| 4 |
Boston Scientific
BSX
|
+$1.86B |
| 5 |
B
Barrick Mining
B
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.17% |
| 2 | Financials | 15.97% |
| 3 | Healthcare | 14.99% |
| 4 | Consumer Discretionary | 9.58% |
| 5 | Industrials | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Descartes Systems
DSGX
$6.57B
| $1.08M | ﹤0.01% |
11,418
+1,034
| +10% | +$106K |
|
1677
Equity Lifestyle Properties
ELS
$12.6B
| $1.07M | ﹤0.01% |
17,606
+1,709
| +11% | +$104K |
|
|
ATXS
1678
DELISTED
Astria Therapeutics
ATXS
| $1.06M | ﹤0.01% |
145,433
-48,316
| -25% | -$327K |
|
|
CPRX
1679
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.04M | ﹤0.01% |
52,978
+6,619
| +14% | +$136K |
|
1680
Tarsus Pharmaceuticals
TARS
$2.67B
| $1.03M | ﹤0.01% |
17,349
-106,287
| -86% | -$5.23M |
|
1681
Editas Medicine
EDIT
$422M
| $1.02M | ﹤0.01% |
+295,257
| New | +$824K |
|
1682
Grupo Cibest SA
CIB
$21.4B
| $1.01M | ﹤0.01% |
19,536
-35,741
| -65% | -$1.73M |
|
1683
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$41.8B
| $1M | ﹤0.01% |
4,945
-4,013
| -45% | -$351K |
|
1684
Inhibrx
INBX
$1.23B
| $1M | ﹤0.01% |
+29,759
| New | +$733K |
|
1685
IDEAYA Biosciences
IDYA
$3.47B
| $1M | ﹤0.01% |
36,778
+943
| +3% | +$22.8K |
|
1686
ADC Therapeutics
ADCT
$136M
| $1M | ﹤0.01% |
+250,084
| New | +$788K |
|
1687
Altimmune
ALT
$589M
| $998K | ﹤0.01% |
264,802
+12,936
| +5% | +$49.9K |
|
1688
PUT
ARK Innovation ETF
ARKK
$6.05B
| $998K | ﹤0.01% |
11,966
-14,194
| -54% | -$1.09M |
|
1689
Cullinan Oncology
CGEM
$1.08B
| $997K | ﹤0.01% |
168,131
-17,952
| -10% | -$131K |
|
1690
Carrier Global
CARR
$53.9B
| $996K | ﹤0.01% |
16,686
-107,140
| -87% | -$7.28M |
|
1691
Aldeyra Therapeutics
ALDX
$96.5M
| $991K | ﹤0.01% |
+189,821
| New | +$990K |
|
1692
OP Bancorp
OPBK
$235M
| $979K | ﹤0.01% |
70,299
| – | – |
|
|
FISV
1693
PUT
Fiserv Inc
FISV
$28.9B
| $973K | ﹤0.01% |
+5,260
| New | +$754K |
|
1694
Organogenesis Holdings
ORGO
$305M
| $967K | ﹤0.01% |
229,141
-190,290
| -45% | -$885K |
|
1695
Capricor Therapeutics
CAPR
$228M
| $954K | ﹤0.01% |
132,315
+438
| +0.3% | +$3.23K |
|
1696
Replimune Group
REPL
$994M
| $951K | ﹤0.01% |
227,016
-717,490
| -76% | -$4.58M |
|
1697
Grand Canyon Education
LOPE
$3.92B
| $944K | ﹤0.01% |
4,302
-8,939
| -68% | -$1.72M |
|
1698
Vanda Pharmaceuticals
VNDA
$306M
| $943K | ﹤0.01% |
189,047
-103,448
| -35% | -$479K |
|
1699
ICL Group
ICL
$6.75B
| $941K | ﹤0.01% |
150,122
+6,193
| +4% | +$39.8K |
|
|
JBIO
1700
Jade Biosciences
JBIO
$1.32B
| $928K | ﹤0.01% |
+107,553
| New | +$879K |
|
Similar funds
Wellington Management Group's Q3 2025 Portfolio in Review
As of Q3 2025, Wellington Management Group held 2,143 positions worth $571B, up 3.7% from $551B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Wellington Management Group's Q3 2025 filing shows 221 new, 777 increased, 828 reduced and 174 closed positions. Its largest new stake was Klarna Group: 9,517,988 shares worth $349M. The largest sale was Broadcom, an estimated $3.35B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
- Wellington Management Group's largest Q3 2025 buy was Klarna Group: 9,517,988 shares worth $349M.
- Wellington Management Group added most to Caterpillar in Q3 2025, an estimated $2.18B increase.
- Wellington Management Group's biggest Q3 2025 reduction was Broadcom, cutting an estimated $3.35B.
- Wellington Management Group fully exited The AZEK Co in Q3 2025, selling an estimated $651M.
- Wellington Management Group's ten largest holdings make up 27% of its $571B portfolio in Q3 2025.
- Wellington Management Group opened 221 new positions and closed 174 in Q3 2025.
- Wellington Management Group's portfolio value rose 3.7% quarter-over-quarter to $571B.
Based on Wellington Management Group's 13F filing for Q3 2025, filed 14 Nov 2025.